---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-018089"
form_type: "8-K"
ticker: "SNGX"
cik: "0000812796"
company_name: "SOLIGENIX, INC."
filed_at: "2022-11-18T23:59:59+00:00"
generated_at: "2026-06-21T16:15:16.046928+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Soligenix receives Nasdaq non-compliance notice for equity deficiency; share increase vote fails

## Summary
- Stockholders' equity of $1,032,002 reported for Q3 2022 falls below Nasdaq's $2.5M minimum.
- Company has 45 days to submit a compliance plan; possible extension of up to 180 days.
- Proposal to increase authorized shares from 75M to 125M failed; 19.25M votes for (80% cast) but not majority of outstanding.
- Management evaluating options to regain compliance; no assurance of success.
- Common stock continues trading on Nasdaq under SNGX pending compliance plan review.

## SEC filing metadata
- accession: 0001558370-22-018089
- form_type: 8-K
- ticker: SNGX
- cik: 0000812796
- company_name: SOLIGENIX, INC.
- filed_at: 2022-11-18T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/812796/000155837022018089/0001558370-22-018089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/812796/000155837022018089/tmb-20221116x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-018089
- JSON: https://secwatch.observer/filing/0001558370-22-018089.json
- Plain text: https://secwatch.observer/filing/0001558370-22-018089.txt

## Key facts
- Listing & Compliance Notices
  SOLIGENIX, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: (the “Stockholders’ Equity Requirement”). In the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, the Company reported stockholders’ equity of $1,032,002, which is below the Stockholders’ Equity Requirement for continued listing. Additionally, as of the date of this report, the Company does not meet either of the alternative Nasdaq
  evidence_url: https://www.sec.gov/Archives/edgar/data/812796/000155837022018089/0001558370-22-018089-index.htm
- Shareholder Votes
  SOLIGENIX, INC. shareholders rejected proposal to approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 75,000,000 to 125,000,000 at the 2022-09-22 meeting.
  - Proposal: charter amendment
  - Outcome: failed
  - Meeting: 2022-09-22
  source text: Despite support for Proposal 2 exceeding 80% of the votes cast on the proposal, Proposal 2 did not receive the affirmative vote of holders of more than 50% of the Company’s issued and outstanding shares of Common Stock and, therefore, was not approved. A large proportion of the stockholders holding shares through banks, brokers or other nominees could not be identified or were unresponsive to the Company’s outreach in urging them to vote their shares. The votes were as follows: For Against Abstain 19,250,158 4,741,417 409,816 There were no broker non-votes on this proposal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/812796/000155837022018089/0001558370-22-018089-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.